New Zealanders will reportedly be the first to trial a new Chinese COVID-19 vaccine.
This is the first time a vaccine that has been developed in China is being tested on humans in a developed country, the South China Morning Post reported.
The vaccine, ReCov, has so far only been tested on animals and showed strong signs of inducing immunity.
Vaccine developer Jiangsu Rec-Biotechnology in China and New Zealand Clinical Research are working together to run the trials in Christchurch and Auckland.
Deputy director of the Jiangsu Centre Zhu Fengcai told the South China Morning Post one of the goals was to eventually launch ReCov in developed countries.
If a first trial is successful, a second trial involving New Zealanders will likely take place, the NZ Herald reported.
Other vaccine trials, like Clover and Advaccine created by Chinese and international partners, have also conducted human trials in Australia.
Newshub has contacted the Ministry of Health for comment.
